Nasdaq

Cognition Therapeutics' Positive Clinical Data from Zervimesine (CT1812) Phase 2 Study in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at AAIC

- Zervimesine-treated participants tested 86% better on behavioral outcomes (NPI 12), 52% on activities of daily living, 91% on cognitive fluctuations, and 62% on motor symptoms as compared to placebo ...
Seeking Alpha

KAHR Bio Announces Oral Presentation of Phase 2 Study of DSP107 in Combination with anti-PD-L1 in Colorectal Cancer at 2025 ASCO Annual Meeting

DSP107 in combination with atezolizumab in 3rd line microsatellite stable colorectal cancer (MSS-CRC) patients elicits anti-tumor activity and extends survival including in patients with liver ...
Cure Today

Phase 2 Study Assessing Alisertib in Metastatic Breast Cancer Subset Begins

ALISCATM-Breast1 study evaluates alisertib in HR-positive, HER2-negative metastatic breast cancer with 150 patients across three dosage groups. Alisertib, an Aurora A kinase inhibitor, is combined ...
Kaleido Scope

Nutrition is not "one-size-fits all." Join the Nutrition for Precision Health research study!

Help our researchers learn how each person's genes, cultural backgrounds, and environment may allow them to tailor diets to individuals and improve overall health in this 2 Phase study. Participants ...